baber/WOPTO huggingface dataset:
Patent NZ-507098-A (NZ)
Title: Label comprising a label body with info on it and a panel with internally printed info
Inventor: BUCKNER MALCOLM
IPC: G09F3/02
Filed: 2000-09-25
Abstract: Label apparatus and methods of forming the label apparatus are disclosed. Label apparatus are formed from a label body, with information on one side and a pressure sensitive adhesive layer on the other side, and a panel adapted to releasably adhere to the label body to conceal part of the information on the label body, and that has further information on at least one face, if not both faces of the panel. Methods for making such labels involve selectively deadening the adhesive layer of a pre-manufactured label stock such that it can be printed on and attached to the label body, with the deadened part being releasably adherent to the label body. This allows the information to be contained in a smaller area than otherwise possible. Additionally, the label may also have a finger lift portion
Patent NZ-508729-A (NZ)
Title: Tracking device using interference and reference signals, and controlling position of reference surface to maintain predetermined point in range of scanning
Inventor: VAN SAARLOOS PAUL PHILLIP
IPC: A61F9/008
Filed: 1999-06-17
Abstract: A method of tracking the position of an object surface (12)  includes  generating  an interference  signal  between light  beams of short temporal coherence length respectively comprising  a primary beam (10) reflected or scattered  from the  object  surface  (12)  and  a  reference  beam  (8).  A reference  surface (14) in the path of said  reference  beam (8)  is  scanned about a position at which the  interference signal is generated, which position is thereby indicative of the  position of the object surface (12). In one aspect, the position  of  the reference surface (14) is controlled  (16, 18)  to  maintain a predetermined point in the range of  the scanning at the indicative position.
Patent NZ-510392-A (NZ)
Title: Humane live-hold bungee operated possum snare
Inventor: RUSSELL ANDREW WAYNE
IPC: A01M23/00
Filed: 2001-03-06
Abstract: A live animal trap comprises of a base plate (1) with an aperture (2), a conduit (7) and a bungee cord (8).  The conduit (7) conveys the bungee cord (8) away from the base plate (1) to be tensioned by an anchor (9).  Bait stations (3) are disposed towards the corners of the base plate (1).  Engaging means (4) for engaging the noose (5) are located about the aperture (2).  A flip-tab (7) is positioned from the base plate (1) and across the aperture (2).  The flip-tab (7) is fixed to the base plate (1) and when depressed by an animal triggers the noose (5) trapping an extremity of the animal.  On inspection the trapped animal is either released or eliminated as desired.
Patent NZ-512101-A (NZ)
Title: Self resetting pest control trap using pyrotechnics to provide a lethal blow to the pest's head
Inventor: ALLEN PETER JEFFREY
IPC: A01M27/00
Filed: 2001-06-01
Abstract: A resettable humane trap for killing animals, particularly but not exclusively for possums, wherein the trap includes means for storage and dispensing of dispensable explosives material into an internal chamber, means capable of sensing a head of an animal when within the trap. The trap includes means for generating at least one explosion within the internal chamber and a killing mechanism having a biased movable member coupled to a moveable wall of the internal chamber, the movable member is capable, on rapid movement driven by an explosion within the chamber of moving from a ready position and delivering a lethal blow to said animal head. The movable member being biased so as to be returned to a ready position, and the trap reset means including a plurality of apertures opening into the internal chamber, and an aperture to allow the killed animal to fall from the trap.
Patent NZ-514258-A (NZ)
Title: Roof construction comprising glazing bars supporting glazing panels
Inventor: RICHARDSON CHRISTOPHER
IPC: E04B7/04
Filed: 2000-02-15
Abstract: A glazed roof comprises glazing bars (14) supporting glazing panels (12) secured to a supporting structure (34) by means of screws (26) through fixing blocks (20) mounted at the glazing bar ends, the fixing blocks having provision (24) for receiving and directing the fixing screws (26).
Patent NZ-519372-A (NZ)
Title: Marker assisted selection of bovine for improved milk composition
Inventor: BLOTT SARAH
Filed: 2002-06-05
Abstract: A method of determining genetic merit of a bovine with respect t milk composition and volume which comprises the step of determining the GHR genotypic state of said bovine, wherein the genotypic state is determined by the presence of Nt 836 (T-A (F279Y)) represented in SEQ ID Nos: 2,4 or 5 either direct or indirect methods.
Patent NZ-524235-A (NZ)
Title: A joint compound additive for reduction of cracking, cratering and shrinkage
Inventor: WAWRZOS FRANK A
IPC: C08K3/00
Filed: 2001-11-16
Abstract: A joint compound composition comprising a latex binder, a filler, water and a surfactant additive consisting of a hydrocarbon substituted sulfate, sulfonate, sulfuric acid or sulfonic acid is disclosed, wherein the hydrocarbon is an aliphatic, olefinic, alicyclic or an aromatic group or combinations thereof, having 12 to 24 carbon atoms . This composition produces a joint compound that shrinks less and is resistant to cracking and cratering.
Patent NZ-525134-A (NZ)
Title: Compositions and methods for use in recombinational cloning of nucleic acids
Inventor: HARTLEY JAMES L
IPC: C12N1/21
Filed: 2000-03-02
Abstract: Described are isolated nucleic acid sequences, and functional mutants, fragments and derivatives thereof. Also disclosed are vectors containing said sequences, cells containing said vectors and kits for synthesising a nucleic acid molecule comprising one of said sequences. (62) Divided out of 514569
Patent NZ-527016-A (NZ)
Title: Cordless drill with metal housing
Inventor: COOPER VINCENT P
IPC: B25F5/00
Filed: 2003-07-15
Abstract: A power tool with a metal housing (12) has a motor positioned within the housing (12). An output, positioned within the housing, is coupled with the motor and is adapted to drive a tool. An activation member (26) is coupled with the motor. A battery pack (30) is electrically coupled with the activation member. The activation member energizes and deenergizes the motor, which in turn, drives the output (22).
Patent NZ-531683-A (NZ)
Title: Method and apparatus for treating a fluid
Inventor: NOTERMANS SERVATIUS HUBERTUS W
IPC: A23C3/00
Filed: 2002-09-06
Abstract: A fluid is passed through pores in an electrically insulating membrane. Arranged on the membrane (10a-2, 20) are conductive layers (22a, 22b), which are interrupted at the pores. Between the two layers a voltage is applied. The fluid to be treated enters the apparatus by inlet (16) and leaves it by outlet (18). The fluid contains micro-organisms or more in general cell material. The voltage is at least so high that a cell wall of the micro-organisms is deactivated (for instance perforated) while they flow through the pores.
Patent NZ-535350-A (NZ)
Title: Interchangeable footwear system
Inventor: BRUCE DARREN PAUL
IPC: A43B3/24
Filed: 2003-03-14
Abstract: An interchangeable footwear system comprising a shoe assembly including: (a) a base shoe; (b) interchangeable covers, in which any one of a plurality of the covers are adapted to allow fitting to the base shoe forming an assembly so as to change the appearance and use environment of the shoe assembly.
Patent NZ-538004-A (NZ)
Title: Method for altering fatty acid composition of milk
Inventor: MORRIS CHRISTOPHER ANTHONY
IPC: A23L1/30
Filed: 2003-07-03
Abstract: A method of determining relative levels of saturated fatty acids and unsaturated fatty acids in bovine milk from one or more cows by the steps of: (a) testing genetic material of the one or more cows for the presence of DNA encoding ~-casein having a proline residue at position 67 or DNA encoding beta-casein having a histidine residue at position 67; (b) identifying whether a cow or cows (i) will likely have a lower percentage of saturated fatty acids and a higher percentage of unsaturated fatty acids based on being homozygous for DNA encoding ~-casein having a proline residue at position 67 or (ii) will likely have a higher percentage of saturated fatty acids and a lower percentage of unsaturated fatty acids based on being homozygous for DNA encoding beta-casein having a histidine residue at position 67 for which genetic material was tested in (a); and (c) obtaining milk from at least one of the one or more cows after step (b).
Patent NZ-541000-A (NZ)
Title: Removable portion of a label
Inventor: MILLER PAUL ANTHONY
IPC: G09F3/10
Filed: 2004-02-27
Abstract: A label is disclosed for affixing to a container of produce, the label (10) including a front portion (16) for carrying labelling indicia; an adhesive backing (18) substantially covering one side of the front portion; a non-stick backing sheet (17, 19) affixed to the adhesive backing, and a token (14) for identifying the produce; a portion of the front portion constituting the token and being readily severable from the front portion when the label is affixed to the container, a portion (24) of the backing sheet being removable from the adhesive backing such that another portion (22) of the backing sheet remains attached to the token; wherein the backing sheet is cut through such that the other portion (22) of the backing sheet which remains attached to the token is smaller than the token, the adhesive where the larger token (14) extends beyond the smaller other portion (22) of the backing sheet being less adhesive than the adhesive backing.
Patent NZ-542616-A (NZ)
Title: P38 inhibitors and methods of use thereof
Inventor: MUNSON MARK
IPC: C07D471/02
Filed: 2004-02-25
Abstract: Disclosed are compounds of formula I, wherein the substituents are as defined in the specification. The compounds are useful for the treatment of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases or neurodegenerative diseases.
Patent NZ-542752-A (NZ)
Title: New non-ionic surfactants for solubilizing poorly soluble molecules
Inventor: CORSWANT CHRISTIAN VON
IPC: A61K9/48
Filed: 2004-04-13
Abstract: Disclosed herein are non-ionic surfactants of formula (I) in the form of polyoxyalkylene glycol hydroxy fatty acid derivatives or monoalkylated polyoxyalkylene glycol hydroxy fatty acid derivatives having a polyoxyalkylene / alkyl polyoxyalkylene chain with a chain-length of 25 - 455 repeating units and a specified substituent on the hydroxy position of the specified hydroxy fatty acid, wherein: R1 is H or C1-C4 alkyl; R2 is C14 - C22 linear or branched, acyl, alkyl or alkenyl wherein the acyl, alkyl or alkenyl may be optionally further substituted with one or more substituents individually selected from the following: halogen, cyano, carboxy, carbamoyl, carbamoyl(C1-C4) alkyl, fluoromethyl, difluoromethyl, trifluoromethyl, mercapto, nitro, amino, (C1-C4) alkylamino, phenyl, naphthyl, phenyloxy, naphthyloxy, (C1-C4) alkylthio, or (C1-C4) alkylsulfinyl; R3 is ethylene, propylene or branched propylene; x is 2-18; y is 1-17; and the sum of (x + y) is 3-19; and z is 25-455. These non-ionic surfactants are prepared by involving an enzymatic process. Formulations comprising the non-ionic surfactants, their use as solubilizers and a process involving a hydrolytic enzyme for preparing them are also disclosed.
Patent NZ-551671-A (NZ)
Title: Method for producing fermented milk and fermented milk by lowering the dissolved oxygen in the raw material mix
Inventor: HORIUCHI HIROSHI
IPC: A23C9/123
Filed: 2005-06-10
Abstract: Discloses a method for producing a fermented milk wherein the dissolved oxygen concentration in a raw material mix for the fermented milk at the start of fermentation is reduced to 5ppm or less by replacement with an inert gas or by other means, fermentation is carried out at a fermentation temperature of 30 to 40°C without the addition of peroxidase.
Patent NZ-554435-A (NZ)
Title: Building panels with aesthetic edges
Inventor: DUBEY ASHISH
IPC: B32B5/16
Filed: 2005-10-25
Abstract: Disclosed is a building composite panel including at least one longitudinal edge. The panel further includes a core of hydraulic cement and a multi-ply edge facing material covering and attached to at least one of the longitudinal edges. The facing material includes at least a first ply configured for embedding in the core as it sets, and at least a second water impermeable ply bonded to the first ply.
Patent NZ-564027-A (NZ)
Title: Anti-GM-CSF antibodies and uses therefor
Inventor: STEIDL STEFAN
IPC: C07K16/24
Filed: 2006-05-17
Abstract: Disclosed are isolated human or humanised antibodies or functional fragments thereof specific for GM-CSF. The disclosed antibodies comprise three heavy chain CDR regions and three light chain CDR regions, as defined in the specification. Furthermore, the antibodies are used in the treatment of rheumatoid arthritis, multiple sclerosis, Crohn's disease, psoriasis, asthma, atopic dermatitis and inflammatory shock.
Patent NZ-564870-A (NZ)
Title: N(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives, preparation and therapeutic use thereof
Inventor: DUBOIS LAURENT
IPC: A61K31/437
Filed: 2006-07-19
Abstract: Disclosed is N-(arylalkyl)-1H-pyrrolopyridine-2-carboxamide derivative corresponding to formula (I) in which n is equal to 0,1,2 or 3, the pyrrolopyridine nucleus is a pyrrolo[3,2-b]pyridine group, a pyrrolo[3,2-c]pyridine group, a pyrrolo[2,3-c]pyridine group or a pyrrolo[2,3-b]pyridine group. The pyrrolopyridine nucleus being optionally substituted in the carbon position 4, 5, 6 and/or 7 with one or more substituents X as defined in the specification. R1 - R5, W and A are also as defined in the specification. Also disclosed is a process to prepare said derivative, a medicament comprising said derivative, a pharmaceutical composition comprising said derivative and the use of said compound in the preparation of a medicament for preventing or treating pathologies in which the TRPV1 receptor is involved for example, pain.
Patent NZ-569769-A (NZ)
Title: Curing agents for epoxy-functional compounds
Inventor: NIXON STEVE ALISTER
IPC: C09D163/00
Filed: 2007-01-15
Abstract: Disclosed is an amide compound, for use as a curing agent for epoxy-functional compound, which is obtained by reacting one or more compounds containing one epoxy group with one or more amides formed by reacting one or more amine-functional compounds having two or more -NH or -NH2 groups with one or more alpha-beta unsaturated acids and/or one or more alpha-beta unsaturated esters. Also disclosed is a curing agent system comprising the above compound, organic solvent and/or water, and optionally a catalyst.
Patent NZ-572784-A (NZ)
Title: A system and article for advertising utilizing golf cup inserts
Inventor: SOPER REGAN
Filed: 2008-11-13
Abstract: An insert 3 for a golf cup which includes: a base 4 having a central hole and one or more drainage apertures; a cylindrical wall 5; - wherein the insert 3 has a shape which substantially corresponds to the internal region of the cup in which the insert 3 fits the insert 3 characterised in that the base 4 and wall 5 both include indicia thereon wherein the cylindrical wall 5 does not extend from the base 4 more than substantially 50% of the height of the cup into which the insert 3 is to be placed.
Patent NZ-579492-A (NZ)
Title: Licence plate device
Inventor: CHILVERS JOHN
IPC: B60Q1/26
Filed: 2009-09-04
Abstract: A licence plate device, comprising a base with a number of visual indicators 20 65 75 placed on it, with the visual indicators 20 65 75 able to show more than one item of information and with the base surrounded by a soft rubber boot 100.
Patent NZ-586521-A (NZ)
Title: Process for the preparation of 5-(2-ethyl-dihydro-1h-inden-2-yl)-1h-imidazole and salts thereof
Inventor: LUSIS VIESTURS
IPC: C07D233/58
Filed: 2008-12-03
Abstract: Disclosed is a process for preparing 5-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-1H imidazole hydrochloride of formula (V) comprising the steps of: a) condensing the 1-trityl-1H-imidazole-4-carboxaldehyde with phtalide to form 2-(1-trityl-1H-imidazole-4-yl)indan-1,3-dione, b) alkylating the product of step (a) with ethyl iodide to form 2-ethyl-2-(1-trityl-1H-imidazole-4-yl)indan-1,3-dione, c) removing the trityl group from the product of step (b) by acid hydrolysis and form 2-ethyl-2-(1 H-imidazol-4-yl)indan-1,3-dione, d) reducing the product of step (c) by catalytic hydrogenation to form the desired 5-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-1H imidazole hydrochloride. Also disclosed are the intermediates 2-(1-Trityl-1H-imidazole-4-yl)indan-1,3-dione and 2-Ethyl-2-( 1-trityl-1H-imidazole-4-yl)indan-1,3-dione.
Patent NZ-587933-A (NZ)
Title: Cerebral blood flow quantification device, cerebral blood flow quantification method and program
Inventor: ABURANO TAMIO
IPC: G01T1/161
Filed: 2009-01-15
Abstract: A cerebral blood flow quantification device that comprises: - a nuclear medicine image acquisition unit for acquiring cephalic nuclear medicine images of a subject having been administered with a radiopharmaceutical; - a count calculation unit for calculating the number of counts obtained from unit areas showing the same site in the cerebral tissue in multiple cephalic nuclear medicine images that are continuously imaged between a first time point and a second time point; - a cerebral blood flow rate calculation unit for computing, for each of the unit areas of the cerebral tissue, the cerebral blood flow rate per unit area that makes the value of a function integrated from the first time to the second time equal to the number of counts calculated by the count calculation unit, the function including cerebral blood flow rate and time elapsed from the administration of the radiopharmaceutical as variables and expressing SPECT or PET counts corresponding to the concentration of the radiopharmaceutical in brain tissue; and - a cerebral blood flow map-forming unit for forming a map showing cerebral blood flow based on the cerebral blood flow rates in the individual unit areas. The cerebral blood flow can be quantified at a high accuracy even in a relatively early stage after the administration of the radioactive drug.
Patent NZ-590389-A (NZ)
Title: Multiple flow conduit flow meter
Inventor: STACK CHARLES PAUL
IPC: G01F1/76
Filed: 2006-08-24
Abstract: A calibration method for a multiple flow conduit vibratory flow meter (200) comprises zeroing out the multiple flow conduit flow meter; zeroing out one or more reference meters in communication with the multiple flow conduit flow meter; measuring a first flow through a first flow conduit of the multiple flow conduit flow meter using the multiple flow conduit flow meter and using the one or more reference meters (293); measuring a second flow through at least one additional flow conduit of the multiple flow conduit flow meter using the multiple flow conduit flow meter and using the one or more reference meters; and determining two or more flow calibration factors (FCFs) for the multiple flow conduit flow meter using a first flow measurement and an at least one additional flow measurement.
Patent NZ-593919-A (NZ)
Title: Improvements in cabinets
Inventor: CUTLER STEPHEN JOSEPH
IPC: H02B1/30
Filed: 2011-07-06
Abstract: 593919 A cabinet including a first area (105) for storing telecommunications equipment and a second area (201) for receiving incoming wire cables and/or fibres is disclosed. The second area (201) has a configuration that has a substantially semicircular footprint and a lower semi circular portion adapted to receive the cables and/or fibres into the box from below. The semi-circular layout allows for easier access to the incoming cables and better use of space. The semi circular second area and the first area are closed and secured by hinged doors (109, 211) which can be locked.
Patent NZ-604533-A (NZ)
Title: An animal shelter having improved interior topography
Inventor: THOMAS GEORGE POW
IPC: A01K1/00
Filed: 2011-12-15
Abstract: An animal shelter (1) is disclosed comprising an overhead roof (2) and flooring (3). The flooring comprises one or more first horizontal permeable regions (4) to provide an animal stand-off pad and one or more raised and sloped second regions (5) forming a ridge. The second region(s) are interspersed between the first regions and are capable of accommodating a substantial portion of an animal such as a cow.
Patent NZ-610247-A (NZ)
Title: Β-lactamase inhibitors and their use
Inventor: UDAYAMPALAYAM PALANISAMY SENTHILKUMAR
IPC: A61K31/34
Filed: 2011-11-25
Abstract: 610247 Disclosed is the use of a compound of formula (I) such as (2S,3S,5R)-3-Methyl-3-(3-methyl-imidazol-3-ium-1-ylmethyl)-4,4,7-trioxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate and (2S,3S,5R)-3-Methyl-3-(4-methyl-3-methyl-imidazol-3-ium-1-ylmethyl)-4,4,7-trioxo-4-thia-1- azabicyclo[3.2.0]heptane-2-carboxylate, in the manufacture of a medicament for the treatment or prevention of carbapenemase-producing bacterial infection. Also disclose is the use of the compound as an in-vitro diagnostic reagent for the detection of carbapenemases.
Patent NZ-612254-A (NZ)
Title: Method and arrangement for receiving an optical input signal and transmitting an optical output signal
Inventor: URBAN PATRYK
IPC: H04B10/556
Filed: 2010-12-20
Abstract: A transceiver unit (140, 150) for receiving an optical input signal and transmitting an amplitude modulated optical output signal is disclosed. The transceiver (140, 150) comprises a first coupler (410) configured to power split input to a receiver (420) and to a second coupler (430), and configured to convert unmodulated optical signal to an electrical output signal. The second coupler (430) is configured to split optical input signal from the first coupler (410) to a first Semiconductor Optical Amplifier, SOA, (440) and a second SOA (450). The first SOA (440) is configured to saturation to erase amplitude modulation of the optical input signal. A phase modulation means (470) connected to the first SOA (440) configured to phase modulate a first saturated optical input signal from the first SOA (440) based on data information to be transferred. First reflection means (480) connected to the phase modulation means (470) configured to reflect a phase modulated first saturated optical input signal from the phase modulation means (470) back into the phase modulation means (470). The second SOA (450) is configured to saturation to erase amplitude modulation of the optical input signal from the second coupler (430). Second reflection means (460) connected to the second SOA (450) configured to reflect a second saturated optical input signal from the second SOA (450) back into the second SOA (450). A method in a transceiver unit (140, 150) for receiving an optical input signal and transmitting an amplitude modulated optical output signal is also disclosed.
Patent NZ-627826-A (NZ)
Title: Antiviral combinations involving (3s,11ar)-n-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
Inventor: UNDERWOOD MARK RICHARD
IPC: A61P31/18
Filed: 2011-01-24
Abstract: Disclosed are combinations of the compound of formula II (3S,11aR)-N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide (also known as cabotegravir and GSK1265744), abacavir or a pharmaceutically acceptable salt thereof and lamivudine. Also disclosed is the use of the combination in the manufacture of a medicament for the treatment of the HIV virus.